Absorbable Antibacterial Envelope Market
Number of pages: 100 | Report Format: PDF | Published date: May 18, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 33.73 million |
|
Revenue Forecast in 2031 |
US$ 56.56 million |
|
CAGR |
5.91% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global absorbable antibacterial envelope market was valued at US$ 33.73 million in 2022 and is expected to register a revenue CAGR of 5.91% to reach US$ 56.56 million by 2031.
Absorbable Antibacterial Envelope Market Fundamentals
An absorbable antibacterial envelope is a medical device used in cardiology. It is designed to reduce the risk of infection associated with cardiac implantable electronic devices (CIEDs) such as pacemakers and implantable cardioverter-defibrillators (ICDs). One of the advantages of using an absorbable antibacterial envelope is that it eliminates the need for long-term antibiotic therapy, which can have associated risks such as antibiotic resistance and side effects. Additionally, the absorbable nature of the envelope means that it does not need to be removed in a separate procedure, as it gradually dissolves within the body.
The industry is comprehensively analyzed in the absorbable antibacterial envelope industry analysis report, along with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the absorbable antibacterial envelope market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the absorbable antibacterial envelope market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
[65546]
Absorbable Antibacterial Envelope Market Dynamics
Cardiac implantable electronic devices (CIED) are commonly used in the management of various cardiac conditions. According to 2022 CDC report, nearly 697,000 people in the U.S. died from heart disease in 2021. Yet, these devices can sometimes become a source of infection. The rising incidence of CIED-related infections has created a need for effective infection prevention measures, driving the demand for absorbable antibacterial envelopes. Healthcare-associated infections (HAIs), including CIED infections, have gained significant attention recently. Healthcare professionals and patients are increasingly aware of the risks associated with these infections and the importance of preventive measures. According to a 2019 BioMed Central article, it was estimated that the prevalence of HAIs in Australia was nearly 165,000 based on yearly data. This awareness has fueled the demand for absorbable antibacterial envelopes as a means to reduce the risk of infection.
The development of innovative materials, antimicrobial agents, and delivery systems has contributed to the evolution of absorbable antibacterial envelopes. Manufacturers are constantly improving the design and functionality of these devices, enhancing their effectiveness and ease of use. Absorbable antibacterial envelopes align with these objectives by providing additional protection against CIED infections. Moreover, reimbursement policies play a crucial role in adopting medical devices. The availability of favorable reimbursement schemes for absorbable antibacterial envelopes can incentivize healthcare providers to incorporate these devices into their practice, thereby driving market growth. The aging population is at a higher risk of developing cardiovascular diseases and requiring CIEDs. As the global population continues to age and the prevalence of cardiovascular conditions rises, the demand for CIEDs and related infection prevention measures like absorbable antibacterial envelopes is expected to increase. Emerging markets are witnessing a rise in healthcare infrastructure development and increased access to advanced medical treatments. This expansion provides opportunities for adopting absorbable antibacterial envelopes as part of the standard care protocols for CIED implantations.
Absorbable Antibacterial Envelope Market Ecosystem
Absorbable Antibacterial Envelope Market, by Application
Absorbable Antibacterial Envelope Market, by End User
Absorbable Antibacterial Envelope Market by Type
[86786]
Cardiac resynchronization therapy defibrillators (CRT-D) segment accounts for significant revenue shares in the global market. CRT-D devices are widely used to manage heart failure patients with an increased risk of arrhythmias. These devices combine the functions of a cardiac resynchronization therapy device and an implantable cardioverter-defibrillator. The high usage and demand for CRT-D devices translate into a larger potential market for associated products like absorbable antibacterial envelopes. The implantation procedure for CRT-D devices is generally more complex and time-consuming than other cardiac implantable electronic devices such as pacemakers. This prolonged procedure may increase the perceived need for infection prevention measures, leading to a higher demand for absorbable antibacterial envelopes. Heart failure patients who require CRT-D devices often have multiple comorbidities and compromised immune systems.
Additionally, they are at an increased risk of infections, including CIED-related infections. Consequently, healthcare providers may prioritize infection prevention strategies for this patient population, including using absorbable antibacterial envelopes. Furthermore, the effectiveness of absorbable antibacterial envelopes in reducing CIED infections may have been studied more extensively about CRT-D devices than other CIED types. Robust clinical evidence demonstrating the benefits of absorbable antibacterial envelopes in CRT-D patients could contribute to their higher utilization in this specific population.
The market segmentation sections provide the absorbable antibacterial envelope market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of industry into subgroups depending on characteristics such as application and end user. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential absorbable antibacterial envelope market demand opportunities.
Absorbable Antibacterial Envelope Market by Region
North America dominates the global market, with more than 42% of shares majorly attributed to the highly developed healthcare infrastructure. The region is equipped with advanced medical facilities, research institutions, and well-established regulatory frameworks. This enables rapid adoption and integration of innovative medical technologies, including absorbable antibacterial envelopes. North America has a relatively high prevalence of cardiovascular diseases, such as heart failure, which often require cardiac implantable electronic devices like pacemakers and implantable cardioverter-defibrillators. The more significant usage of CIEDs in the region increases the demand for infection prevention measures like absorbable antibacterial envelopes. North American healthcare systems emphasize patient safety and infection control. Hospitals and healthcare facilities in the region follow strict protocols to minimize the risk of healthcare-associated infections. Absorbable antibacterial envelopes offer additional protection against CIED-related infections, aligning with these infection control standards. North America is a hub for medical research and development. The region hosts leading medical device manufacturers, research institutions, and academic centers. This fosters the development and commercialization of innovative medical technologies, including absorbable antibacterial envelopes. The presence of a robust research ecosystem contributes to the dominance of North America in the market. Reimbursement policies play a crucial role in the adoption of medical devices.
Based on the regions, the global absorbable antibacterial envelope market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of absorbable antibacterial envelope industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level absorbable antibacterial envelope market overview.
Key Components of the Report
Absorbable Antibacterial Envelope Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Absorbable Antibacterial Envelope Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
A heart-implantable electronic device or an implanted neurostimulator is protected by an absorbable antibacterial envelope. Its function is to stabilize the implanted device as well as to release antibacterial medications.
The market size of the absorbable antibacterial envelope market in 2022 was 33.73 million in 2022
North America accounts for the largest global absorbable antibacterial envelope market revenue share.
The global absorbable antibacterial envelope market is estimated to grow at a revenue CAGR of 5.91% from 2023 to 2031
The rising prevalence of cardiovascular diseases and cardiac implantable electronic device infections are the prominent trend in the global absorbable antibacterial envelope.
Technological advancements and rising awareness are a few opportunities in the global absorbable antibacterial envelope market.
Stringent regulatory policies and low adoption rates are some of the restraining factors that can hamper overall market growth.
Medtronic Plc. and Aziyo Biologics Inc. are the key market players in the global absorbable antibacterial envelope market.
Cardiac resynchronization therapy defibrillators segment accounts for the highest revenue share in the global market
*Insights on financial performance are subject to the availability of information in the public domain